Ladenburg Thalmann Starts BioTime, Inc. (BTX) at Buy
News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.
Ladenburg Thalmann initiated coverage on BioTime, Inc. (NYSE: BTX) with a Buy rating and a price target of $6.00.
Shares of BioTime, Inc. closed at $3.59 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATE: Oppenheimer Starts Fortive (FTV) at Perform
- Buckingham Research Starts Kansas City Southern (KSU) at Buy
- Deutsche Bank Starts Danaher (DHR) at Buy
Create E-mail Alert Related CategoriesNew Coverage
Related EntitiesLadenburg Thalmann Financial Services
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!